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Abstract
Background: Knowledge of the effect of marine protein hydrolysate (MPH) supplementation to promote recovery
after high intensity performance training is scarce. The aim of this study was to examine the effect of MPH
supplementation to whey protein (WP) and carbohydrate (CHO): (CHO-WP-MPH), on short-term recovery following
high intensity performance, compared to an isoenergetic and isonitrogenous supplement of WP and CHO: (CHO-WP),
in male cyclists.
Methods: This was a double-blinded crossover study divided into three phases. Fourteen healthy men participated. In
phase I, an incremental bicycle exercise test was performed for establishment of intensities used in phase II and III. In
phase II (9–16 days after phase 1), the participants performed first one high intensity performance cycling session, followed
by nutrition supplementation (CHO-WP-MPH or CHO-WP) and 4 hours of recovery, before a subsequent high
intensity performance cycling session. Phase III (1 week after phase II), was similar to phase II except for the
nutrition supplementation, where the participants received the opposite supplementation compared to phase
II. Primary outcome was difference in time to exhaustion between the cycling sessions, after nutrition supplementations
containing MPH or without MPH. Secondary outcomes were differences in heart rate (HR), respiratory exchange ratio
(RER), blood lactate concentration and glucose.
Results: The mean age of the participants was 45.6 years (range 40–58). The maximal oxygen uptake (mean ± SD)
measured at baseline was 54.7 ± 4.1 ml∙min− 1∙kg− 1. There were no significant differences between the two nutrition
supplementations measured by time to exhaustion at the cycling sessions (meandiff = 0.85 min, p = 0.156, 95%
confidence interval (CI), − 0.37, 2.06), HR (meandiff = 0.8 beats pr.min, p = 0.331, 95% CI, − 0.9, 2.5), RER (meandiff = − 0.05,
p = 0.361, 95% CI -0.07 – 0.17), blood lactate concentration (meandiff = − 0.24, p = 0.511, 95% CI, − 1.00, 0.53) and
glucose (meandiff = 0.23, p = 0.094, 95% CI, − 0.05, 0.51).
Conclusions: A protein supplement with MPH showed no effects on short-term recovery in middle-aged
healthy male cyclists compared to a protein supplement without MPH.
Trial registration: The study was registered 02.05.2017 at ClinicalTrials.gov (Protein Supplements to Cyclists,
NCT03136133, https://clinicaltrials.gov/ct2/show/NCT03136133?cond=marine+peptides&rank=1.
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Background
Appropriate recovery from strenuous exercise is essential
both during exercise training and during competitions to
maximize physiological adaptations. In cycling, repeated
high performance activity is often required after only short
time of recovery. Rapid replenishment of energy stores,
like muscle and liver glycogen, is therefore necessary, as
well as rapid muscle repair and remodelling [1, 2].
Adequate nutrition is vital for optimal recovery, and
the importance of protein intake during brief recovery
periods is well accepted [3]. However, less is known
about the role of protein intake in endurance exercise
compared to resistance-based exercise [1].
Protein nutrition is complex, and multiple factors, in
addition to the amount of protein ingested, are regarded
to be relevant for training adaptations [1, 4–6]. Amino
acid composition, digestibility and rate of absorption
may differ between proteins strongly affecting their nu-
tritional qualities. During the last decades, whey proteins
(WP) have become very popular in sports nutrition, and
considered superior to other proteins due to their excel-
lent amino acid profile, high digestibility and the fact
that they are rapidly absorbed from the intestine [1].
Recently pre-digested proteins produced by enzymatic
hydrolysis turning the protein into peptides [7], has
gained interest in sports nutrition due to their more rap-
idly uptake from the intestine as compared to free amino
acids and proteins [7–9]. In addition to rapid supply of
amino acids for protein synthesis in tissues, pre-
digestion of proteins may produce bioactive peptides
specifically affecting secretion of hormones related to re-
covery, which is not obtained by the undigested protein
[10]. Inclusion of hydrolysed proteins in sports nutrition
may be beneficial for recovery both by faster regener-
ation of the glycogen stores, but also by triggering anab-
olism of protein in muscle tissue [11].
Marine protein hydrolysates (MPH), have gradually
gained more attention due to potential health benefits
[12], and substantial effects of hydrolysed fish proteins
on metabolism have been shown in rats [13, 14]. In a
clinical study, comprising 120 overweight male and
female subjects, Nobile et al. [15] showed that oral doses
of 1.4 and 2.4 g of MPH taken daily for 90 days, signifi-
cantly affected cholecystokinin (CCK) and glucagon-like
peptide-1 (GLP-1). In addition, improved body compos-
ition in favour of protein body mass was demonstrated,
indicating that MPH show bioactivity in humans when
taken orally at doses in the range of 15–20mg per kg
body weight [15].
Two randomized controlled studies with crossover
design and great similarities in methods, investigated ef-
fects of MPH ingestion during endurance cycling in men
[16, 17]. Vegge et al. [17] found no influences of MPH
on metabolism. They did however find improved cycling
performance in those participants with the lowest aer-
obic capacity, and thus indicated that MPH provide
ergogenic effects in less trained athletes. Interestingly,
and contrary to the results found by Vegge et al. [17],
Siegler et al. [16] demonstrated metabolic influences of
MPH, but could not show effects on performance.
As only a few studies have examined effects of MPH
on endurance performance and found discrepant results
[16, 17], more knowledge about the potential role of
MPH in endurance exercise and high intensity perform-
ance is needed. The aforementioned studies were not
concerned with recovery, and to our knowledge, no
studies have investigated effects of MPH supplementa-
tion on recovery after high intensity performance exer-
cise. Furthermore, there has been a lack of evidence on
effects of protein nutrition on recovery in middle-aged
adults [5]. The main objective of the present study was
therefore to examine the effect of MPH supplementation
in addition to WP and carbohydrate (CHO) on recovery
regarding time to exhaustion after high intensity per-
formance cycling in middle-aged men, compared to an
isoenergetic and isonitrogenous supplement of WP and
CHO. We hypothesized that low concentrations of
MPH, in combination with WP, enhances recovery more
than an isonitrogenous amount of WP without MPH.
Methods
Study design and procedure
This was a double-blinded crossover study divided into
three phases, as shown in Fig. 1, and the study was a
part of a larger trial. Assessment of health status, meas-
urement of body composition and testing of maximal
aerobic capacity were evaluated in phase I. In phase II,
the participants performed a high intensity performance
cycling session until exhaustion, before nutrition supple-
mentation and a recovery phase of 4 hours, before a new
cycling session equal to the first one was performed.
Phase III was similar to phase II except for the nutrition
supplementation. There were two alternative diets, com-
posed of WP and CHO, with or without supplementation
of MPH (CHO-WP-MPH or CHO-WP). The participants
could receive either CHO-WP or CHO-WP-MPH in
phase II, and the opposite alternative in phase III. The
study was conducted at Western Norway University of
Applied Sciences from September to November 2017.
Participants
Fourteen healthy male volunteers, with cycling as their
main exercise activity, were included in the study. They
were recruited through advertising in social media, and
from local cycle clubs in Bergen and the surrounding
municipalities, Norway.
To avoid hormone differences between individuals, no
women were recruited. Eligibility criteria were healthy
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men between 38 and 55 years of age (changed from 40
to 50 years registered in ClinicalTrials.gov), with a body
mass index (BMI) from 19 to 29 kg/m2, who exercised
on average between 8 and 12 h per week the last month
prior to inclusion, and at least 70% of the exercise had
to be cycling. Exclusion criteria were food allergies, self--
reported diabetes mellitus, surgery or trauma with sig-
nificant blood loss or donation of blood within the last 3
months prior to the study. Musculoskeletal problems
that could interfere with their ability to perform the cyc-
ling sessions were also cause for exclusion. In addition,
participants who had human immunodeficiency virus
(HIV), hepatitis B surface antigen (HBsAg), or hepatitis
C virus antibody (anti-HCV) and/or had been treated
with any investigational drugs, steroids, or medications
that effected the intestinal function within 1 month prior
to the study or use of antibiotics within 3 months prior
to the study were excluded.
The study was conducted according to the declaration
of Helsinki and the Western Norway Regional Commit-
tee for Medical and Health Research Ethics (REK 2017/
56) approved the study. Written informed consent was
obtained from all participants prior to inclusion.
Intervention and procedures
The participants were instructed to abstain from exercise
24 h prior to the testing in phase I, II and III, and they ar-
rived at the laboratory by car or by public transportation.
They were recommended to maintain approximately the
same training frequency, volume and intensity between
phase II and III, as in the last week before phase II. In
addition, they were told not to drink more than five cups
of coffee per day during the study period and to refrain
from alcohol 48 h prior to each visit.
Phase I
Health status
Health status was assessed based upon a self-reported
questionnaire and a further evaluation when necessary
as judged by the physician.
Body composition
Height and weight were recorded, including measure-
ment of body composition by use of InBody 720 (InBody
Co., Ltd., Cerritos, California, USA). Measurements of
body composition included total body weight and height,
BMI, fat mass, fat free mass and muscle mass. The BMI
Fig. 1 Flowchart of the study. V̇O2max: Maximal oxygen uptake
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was calculated as the body mass divided by the square of
height. Measurements were conducted without shoes
and socks, and the participants were wearing cycling
clothes.
Incremental step exercise test
An incremental step exercise test was conducted on a
bicycle ergometer to establish the relationship between
workload (Watt/W) and oxygen uptake (V̇O2), and to
measure maximal oxygen uptake (V̇O2max) (Jaeger Oxy-
con Pro GmbH, Würzburg, Germany).
The test started with a warm-up phase at 100W for 8
min. The workload was then increased by 25W every 4th
min until the blood lactate threshold (LT) was reached.
The LT was defined as 1.5 mmol/L above the lowest blood
lactate level measured according to methods described by
Borch et al. [18]. The cycling was performed with a pedal
frequency of 90 revolutions per minute (rpm). Tidal vol-
ume (VT), breathing frequency (Bf), V̇O2, carbon dioxide
output (V̇CO2) and respiratory exchange ratio (RER) were
measured during a period of 60–90 s on each workload.
At the end of each workload, heart rate (HR) (Polar Elec-
tro OY, Kempele, Finland or Garmin Edge 1000, Garmin
Ltd., Schaffhausen, Switzerland) and perceived exertion by
use of the Borg RPE scale 6–20 («rating of perceived exer-
tion», RPE) [19] were registered. After each step a meas-
ure of capillary blood lactate and glucose were taken from
the fingertip and immediately analysed (Biosen C-Line,
EKF Diagnostics Holdings plc, Cardiff, United Kingdom).
After reaching a blood lactate level of 1.5 mmol/L
above the lowest measure, the test for V̇O2max was
performed immediately by increasing the workload with
25W every 30 s until exhaustion. During this maximal
exercise test, VT, Bf, V̇O2, V̇CO2, RER and HR were
measured continuously until exhaustion, and at exhaus-
tion the Borg RPE was registered immediately, as well as
measurements of blood lactate and glucose.
The participants were cycling either on a Lode Excalibur
Sport ergometer (Lode B.V., Groningen, The Netherlands),
or on a Velotron bicycle ergometer (RacerMate Inc.,
Seattle, Washington). Each participant performed every
cycling session on the same bike throughout the study. In
addition, all individual adjustments for seating position,
like the height and angle of the saddle and the handlebar,
were identical every time for the same participant.
Gas exchange and ventilatory variables during all cycling
sessions were measured using a mixing chamber. The mi-
nute ventilation was corrected to the body temperature
pressure saturated condition, and V̇O2 and V̇CO2 to the
standard temperature pressure dry condition.
Phase II
In phase II, 9–16 days after phase I, the participants per-
formed two high intensity performance cycling sessions
with nutrition supplementation and 4 hours of recovery
between the sessions.
Phase II involved the following procedures: The partic-
ipants had a standardized light breakfast meal 1 hour
prior to the first high intensity cycling session. Immedi-
ately after the cycling session, the participants ingested
the nutrition supplementation. After 4 hours of recovery,
the cycling session was repeated.
Following both cycling sessions, venous blood samples
were taken after 0, 15, 30, 60, 90 and 120min. At similar
time intervals, the participants filled out questionnaires
regarding hunger, satiety, abdominal pain, nausea, diar-
rhoea and desire to eat. Urine was collected during the
whole day. Results from these measurements are beyond
the scope of this article and will not be presented here.
Two hours into the four-hour recovery period, the
participants were served a standardized warm meal.
They were allowed to drink a total of 2.5–3 l of water
during the day.
High intensity performance cycling sessions
The cycling sessions were initiated with a 20min moder-
ate intensity at 60% of V̇O2max. The exercise load was
then increased directly to 90% of V̇O2max for 5 min.
Finally, the participants were cycling on a workload cor-
responding to 95% of V̇O2max until exhaustion. Linear
regression analyses were used to determine the relation-
ship between the workload (W) and V̇O2 measured in
phase I, and the W at the given intensities relatively to
V̇O2max were further determined based on individual
V̇O2max values. The participants were instructed to keep
a pedalling frequency of 90 rpm, and exhaustion was
achieved when the frequency fell below 80 rpm. The
time to exhaustion performed at 95% of V̇O2max was
registered. V̇O2, V̇CO2 and RER were measured between
9 and 10min at 60% of V̇O2max, and between 3 and 4
min at 90% of V̇O2max. HR and Borg RPE were regis-
tered every 5 min throughout the cycling sessions, and at
exhaustion. Blood lactate concentration and glucose
were measured before and immediately after each high
intensity cycling session.
The participants were blinded for time to exhaustion
when cycling at 95% of V̇O2max.The cycling sessions
were supervised by experienced technicians. The partici-
pants were informed about rpm during the sessions
when needed, but to obtain high test-retest reliability,
there was no cheering or encouragement during the cyc-
ling sessions.
Nutrition supplementation
Participants reported to the laboratory in the fasted
state. They received a standardised breakfast meal com-
prising a baguette of semi-coarse bread (93 g) with ham
(25 g), white cheese (33 g), no butter, coffee (200 mL)
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and a glass (200 mL) of orange juice, in total 450 kcal
and 22 g protein (19.5% (protein energy/total energy)
followed by 1 hour rest before the first cycling session.
Immediately after the bout, the participants ingested the
test or placebo drink, followed by blood sampling (T =
0), and then sampling at intervals for 120 min whilst
resting. Then they received a ready-to-use hot meal
(Beef Stroganoff with rice, produced by Fjordland,
Norway), containing 450 kcal distributed between 57%
CHO, 25% protein and 18% fat, whilst resting for an-
other 2 hours before entering the second cycling bout.
The participants were allowed to drink a total of 2.5–3 l
of water throughout the intervention day.
The nutrition supplementations CHO-WP (placebo)
and CHO-WP-MPH (test) were given in the form of a
powder dissolved in water. The powders contained 4.2
kcal/gram distributed, in terms of total energy, between
12% from protein, 66% from CHO, and 22% from fat.
WP (WPC80/TINE, Norway) was used as the basic
source of protein, while the sources of CHO and fat
were, respectively, maltodextrin (DE 20) from corn, and
vegetable medium chain triglyceride (MCT) powder
(BERGAMAST), i.e. MCT coated with maltodextrin at
the ratio 70:30, respectively. The powders were slightly
acidified with citric acid and flavoured with a strawberry
flavouring agent (Firmenich SA, Switzerland) to level out
any differences in terms of taste or smell. The serving
size of the powders was standardized to 80 kg body
weight providing 295 kcal in 70 g of powder giving 3.68
kcal/kg bodyweight, and 20mg MPH in the test powder
equal to a serving size of 1.600 mg in terms of protein
(Nx6.25). The placebo powder was made by replacing
MPH with equal amounts of WPC80 in terms of protein
(Nx6.25) making the powders both isonitrogenous and
isoenergetic. By adjusting the amount of powder to their
body weight each participant was given equal amounts
of MPH-protein or placebo-protein (WPC80) as well as
total protein, carbohydrate, fat and energy in terms of
body weight. The difference in the amino acid profiles
between MPH and WP was considered insignificant.
The beverages were made by dissolving powder in cold
water at a ratio 1:2 30 min prior to use to form creamy
drinks.
The MPH was provided by Firmenich Bjorge Biomarin
AS, Ellingsoy/Norway, and was industrially produced by
enzymatic hydrolysis of fresh frozen meat from Atlantic
cod (Gadus morhua) using the food approved enzyme
preparation Protamex® (Novozymes, Copenhagen). The
hydrolysate was spray-dried into a powder containing
89% crude protein and < 0.5% fat. The molecular weight
(MW) profile of the MPH was analysed by Firmenich-
Geneve/Switzerland using size exclusion chromatog-
raphy (Supradex Peptide 10/300 GL (GE Healthcare,
Uppsala-Sweeden)) and UV detection (SEC/UV), and
free amino acids by HPLC and Waters Pico-Tag method
using UV detection. The analyses showed that about
90% of the peptides had MW less than 2.000 Da (i.e. 18
amino acids or less), about 75% with MW less than
1000 Da (i.e. 10 amino acids or less), and 55% with MW
less than 500 Da (i.e. 5 amino acids or less). Twenty-five
to 30% of the peptides had MW less than 200 Da repre-
senting small dipeptides and free amino acids, the latter
accounting for 4.5% of the hydrolysate.
Procedures and blinding
The nutrition supplementations were provided, randomly
numbered, from the manufacturer (Firmenich Bjørge Bio-
marin AS, Aalesund/Norway). An experienced biochemist
was responsible for composition and blinding of the diets.
In phase II, the participants chose one of two alternative
drinks, from identically looking bottles, hereby determin-
ing the sequence of the diets. In phase II, five participants
chose drinks containing MPH, and nine in phase III. The
technicians and the participants were all blinded for the
contents throughout the study, and the researchers were
blinded during the statistical analyses.
Phase III
The participants returned for crossover testing after a
washout period of seven days to repeat the procedures
described in phase II. The time of the day was the same
for each participant as they met at the same time in the
morning in phase II and III in order to avoid circadian
variance. The only difference from the protocol was the
administration of the alternative beverage.
Outcome measures
Primary outcome in this subanalysis was differences in
performance between cycling sessions after diets with
MPH compared to diets without MPH, measured by
time to exhaustion at 95% of V̇O2max. Secondary out-
comes were differences in HR, RER, glucose and blood
lactate concentration after diets with MPH compared to
diets without MPH.
Statistics
Because less is known about MPH and possible ergo-
genic effects, compared to indications from previous
studies regarding influences of MPH on glucose [20, 21],
power estimation in the main trial was calculated based
on blood sugar profile. With an estimated change in
mean blood sugar profile (area under the curve) of 20%,
power of 80%, type 1 error of 0.05 and a standard devi-
ation of 10% the power calculations estimated that 14
participants had to be included in the study.
Descriptive statistics were used to characterize the
participants (mean, standard deviation (SD) median and
percent). Paired samples t tests were used for comparison
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between cycling sessions and between the sequences of
the nutrition supplementations, CHO-WP versus CHO-
WP-MPH (mean, SD and 95% confidence interval (CI)).
The outcome variables were differences in cycling time at
95% of V̇O2max, RER measured at 90% of V̇O2max, and
HR, glucose and blood lactate measured at the end of the
cycling sessions in the morning versus in the afternoon
were compared.
We did not ensure equal distribution of CHO-WP-
MPH and CHO-WP in phase II and III. However, we
found no period or sequence effects on the various
outcomes.
The significance level was set at 0.05. The statistical
analyses were carried out using IBM SPSS Statistics 24
for windows (SPSS Inc., Chicago, Illinois, USA) and R




Fourteen men were included and all participants com-
pleted all phases as planned. Characteristics of the partici-
pants at baseline are presented in Table 1. Summarized,
mean age was 45.6 ± 5.3 years (range 40–58), and BMI
was 24.5 ± 2.2 kg/m2. The mean exercise capacity, mea-
sured as V̇O2max, was 54.7 ± 4.1 ml∙min
− 1∙kg− 1, the mean
workload at maximal exertion was 422 ± 32W and the
median Borg RPE was 19 at the end of the test.
High intensity performance cycling sessions
The average workloads (W) at the high intensity per-
formance cycling sessions were 174.7 ± 22.1W, 301.3 ±
31.3W and 322.5 ± 32.9W at 60, 90 and 95% of V̇O2max
respectively. The median Borg RPE registered at exhaus-
tion was 19 in both morning and afternoon cycling
sessions in phase II, and 19 and 20 in morning and after-
noon cycling sessions respectively in phase III.
Results from the high intensity performance cycling
sessions (phase II and III) in the morning and in the
afternoon are presented in Table 2. When CHO-WP-
MPH was consumed, the cycling time at 95% of V̇O2max
was 6.2 ± 4.6 min (total cycling time 31.2 ± 4.6 min) in
the morning sessions and 4.8 ± 3.1 min (total cycling
time 29.8 ± 3.1 min) in the afternoon sessions, a reduc-
tion in time of 1.4 ± 2.0 min (p = 0.026). When CHO-WP
was consumed, the cycling time at 95% of V̇O2max was
6.0 ± 4.5 min (total cycling time 31.0 ± 4.5 min) and
5.5 ± 4.6 min (total cycling time 30.5 ± 4.6 min) in the
morning and in the afternoon sessions respectively, giv-
ing a reduction time of 0.5 ± 1.2 min (p = 0.121). Lactate
(p < 0.001) and glucose (p = 0.015) were lower in the
morning compared to the afternoon exercise sessions in
both conditions (Table 2). Neither HR nor RER changed
significantly after recovery in either condition.
CHO-WP-MPH compared to CHO-WP
When comparing the differences between the high in-
tensity performance cycling sessions in the morning and
afternoon in the CHO-WP-MPH condition to the differ-
ences between morning and afternoon sessions in the
CHO-WP condition, there were no significant differ-
ences between conditions regarding time to exhaustion
at 95% of V̇O2max, RER, lactate, glucose or HR (Table 3).
Cycling performance was, with the exception of two
participants, better in the morning compared to the
afternoon. Time to exhaustion at 95% of V̇O2max was
less reduced in the afternoon when CHO-WP had been
consumed (11 ± 26%), compared to CHO-WP-MPH
(20 ± 18%). However, the difference of 9% (95% CI,-4.65,
22.29) between conditions was not significant (p =
0.181). The difference in performance between morning
and afternoon cycling sessions are reported in minutes
in Fig. 2 and Table 3.
Discussion
We examined the effect of MPH supplementation on
recovery after high intensity performance cycling. The
main finding was that supplementation with MPH in
addition to WP and CHO could not improve recovery
after high intensity performance cycling in middle-aged
men compared to supplementation with CHO-WP.
The cycling time at 95% of V̇O2max was less reduced
in the afternoon sessions when CHO-WP had been
Table 1 Baseline characteristics of the participants and
physiological responses to the incremental exercise test on
treadmill
Characteristics (N = 14) Mean
Age (years) 45.6 ± 5.3
Height (cm) 181 ± 4
Weight (kg) 80.1 ± 6.4
BMI (kg/m2) 24.5 ± 2.2
Muscle mass (kg) 37.7 ± 2.3
Fat mass (%) 16.6 ± 4.4
V̇O2max (ml∙min
−1∙kg− 1) 54.7 ± 4.1
Workloadmax (Watt) 422 ± 32
RERmax 1.20 ± 0.10
V̇Emax (L/min) 167 ± 16
Lactatemax (mmol/L) 11.2 ± 1.4
HRmax (bpm) 185 ± 8
Glucosemax (mmol/L) 4.8 ± 1.1
Borg RPEmax (median) 19
Data are presented as mean ± standard deviation (SD) unless
otherwise stated. BMI: body mass index; V̇O2max: maximal oxygen uptake;
RER: respiratory exchange ratio; V̇E: ventilation; HR: heart rate; RPE: rating of
perceived exertion
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consumed compared to CHO-WP-MPH. This could
possibly indicate that the beverage without MPH was
most effective. However, the difference was not consist-
ently observed across participants, and the statistical
analysis did not provide evidence that MPH influenced
recovery in either direction (p = 0.181).
To our knowledge, this is the first study to examine if
MPH from Atlantic cod has effect on recovery after high
intensity performance cycling. A major strength of the
present study is the comparison of isoenergetic and iso-
nitrogenous beverages. WP has a high rate of digestibil-
ity and stimulates muscle protein synthesis after exercise
more than other protein sources, and the superior effects
of WP on recovery compared to other protein sources
are well established [1, 5]. Based on the results from
Chevrier et al. [20], we hypothesized that MPH in low
concentrations could act synergistically with WP,
thereby enhancing and accelerating recovery processes
beyond what could be expected of CHO and WP alone.
Physiological effects of small concentrations of fish
protein hydrolysate on metabolism have been observed
[20], and the current dose of MPH was hypothesized to
be sufficient to achieve bioactivity [15]. However, in this
study, additional effects of MPH were not found. Since
the beverages in both conditions had a high content of
WP, in addition to CHO, and only a small part (3.2%) of
the WP was replaced by MPH in the CHO-WP-MPH
beverage, it is possible that the recovery processes influ-
enced by nutrition were already optimal without MPH,
or that the current dose of MPH was not sufficient.
In addition, we aimed to replicate common post-exercise
circumstances in the recovery period, and the cyclists
therefore consumed a warm meal after 2 hours of recovery.
This already reasonable nutrition, in addition to the opti-
mal content of CHO and WP in both beverages, is
regarded a great strength of this study, as it represents
habitual post-exercise strategies. However, these nutritional
strategies could represent limitations as well, because
effects of MPH in small concentrations could be difficult
to reveal under otherwise optimal circumstances. Future
studies investigating MPH should probably consider differ-
ent protein source compositions, possibly including larger
doses of MPH as well.
With attention to the experimental design of the
present study, both the high intensity performance cyc-
ling protocols with relatively short durations, and the
Table 2 Morning and afternoon cycling sessions when CHO-WP-MPH and CHO-WP were consumed
CHO-WP-MPH CHO-WP
N = 14 N = 14
Morning Afternoon Morning Afternoon
Mean ± SD Mean ± SD p-value Mean ± SD Mean ± SD p-value
Time at 95% of V̇O2max (min)
1,2 6.2 ± 4.6 4.8 ± 3.1 0.026 6.0 ± 4.5 5.5 ± 4.6 0.121
HR (bpm)2 181 ± 8 180 ± 8 0.166 182 ± 7 180 ± 7 0.052
RER3 1.06 ± 0.04 1.06 ± 0.04 0.486 1.05 ± 0.05 1.11 ± 0.22 0.331
Lactate (mmol/L)2 13.1 ± 2.1 11.3 ± 2.3 < 0.001 13.2 ± 2.0 11.1 ± 2.2 < 0.001
Glucose (mmol/L)2 5.4 ± 1.4 4.6 ± 1.1 0.001 5.2 ± 1.5 4.6 ± 1.0 0.015
Data are presented as mean values± standard deviations (SD). The P-value represents the significance level of the difference between the morning and the
afternoon cycling sessions for CHO-WP-MPH and CHO-WP, respectively. CHO, carbohydrate; WP, whey protein; MPH, marine protein hydrolysate; V̇O2max, maximal
oxygen uptake; HR, Heart rate; RER, respiratory exchange ratio. 1Performance at cycling sessions measured as time to exhaustion (min) when cycling at a workload
corresponding to 95% of V̇O2max.
2Measured at the end of the cycling sessions. 3RER measured at 90% of V̇O2max
Table 3 Differences between morning minus afternoon cycling sessions for CHO-WP-MPH and CHO-WP and comparison of the
diets
aCHO-WP-MPH aCHO-WP Diff. CHO-WP-MPH versus
N = 14 N = 14 CHO-WP
Mean diff ± SD Mean diff ± SD Mean diff 95% CI p-value
bTimediff at 95% of V̇O2max (min) 1.37 ± 2.03 0.52 ± 1.17 0.85 −0.37, 2.06 0.156
HR (bpm) −0.9 ± 2.4 −1.7 ± 3.0 0.8 −0.9, 2.5 0.331
RER −0.01 ± 0.03 −0.06 ± 0.21 − 0.05 −0.07, 0.17 0.361
Lactate (mmol/L) 1.88 ± 0.83 2.12 ± 1.02 −0.24 −1.00, 0.53 0.511
Glucose (mmol/L) 0.78 ± 0.65 0.55 ± 0.73 0.23 −0.05, 0.51 0.094
Data are presented as mean values, standard deviations (SD), 95% confidence interval (CI), and P-value. Diff. CHO-WP-MPH versus CHO-WP: differences between
morning and afternoon cycling sessions with ingestion of CHO-WP-MPH versus CHO-WP. a Five participants ingested CHO-WP-MPH and nine CHO-WP in the first
intervention (phase II) and in the second intervention (phase III) nine participants ingested CHO-WP-MPH and five CHO-WP. b Timediff at 95% of V̇O2max,:
differences between cycling time in the morning and in the afternoon at 95% of V̇O2max. CHO, carbohydrate; WP, whey protein; MPH, marine protein hydrolysate;
diff, difference; HR, Heart rate; bpm, beats pr. min; RER, respiratory exchange ratio
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recovery period of only 4 hours, need to be discussed.
As for the former, it could be questioned whether the
cycling sessions were demanding enough in order to
expect benefits from the nutrition supplementations.
Cycling at 95% of V̇O2max led to exhaustion, and blood
lactate levels, HR and Borg RPE confirmed that the high
intensity performance cycling sessions in the morning
were quite demanding for the participants.
In several previous studies where effects of protein sup-
plements on recovery after cycling have been examined,
the cycling protocols had longer duration compared to
our study, aiming not only to exhaust the cyclists, but to
empty glycogen stores as well [22–24]. With a total dur-
ation of 31.1 ± 4.4min at morning sessions in the current
study, including 20min performed at an intensity corre-
sponding to 60% of V̇O2max, we could not expect glycogen
depletion [25], nor did we aim to deplete endogenous fuel
stores. In addition, any metabolic effects of fish protein
hydrolysates [13, 14] could be difficult to confirm with a
cycling protocol of relatively short duration, which does
not depend much on fatty acid metabolism. We aimed to
examine ergogenic effects after short time of recovery and
wanted a corresponding cycling protocol of short dur-
ation. It is reasonable to believe that the relatively short
duration and high intensity ensured that fatigue occurred
when physiological limits were reached, not influenced by
psychological processes and motivation. Therefore, we
assume that the reliability of measurements from the exer-
cise sessions was high. In addition, the procedures related
to the high intensity performance cycling sessions ensured
blinding of time at 95% of V̇O2max, as well as strict
regulation of verbal instructions. This increased the
methodological strength and reduced the possibility
that motivation could influence outcomes in this study.
As previously mentioned, the recovery period of only 4
hours in the current study is relatively short. Several
studies have used longer periods of recovery when inves-
tigating effects of nutritional supplements on recovery,
for example 12–15 h [26], 18 h [27], and 24–72 h [28].
However, shorter recovery periods have been described
as well, and effects of protein ingestion in combination
with CHO on recovery have been demonstrated after
three [29] and 4 hours of recovery [24]. The relatively
short recovery time can represent a limitation in our
study. Still, it could just as well be an advantage, as
protein supplements could be of greater benefit with
regard to protein synthesis and glycogen repletion when
recovery time is insufficient [3].
We did not perform block randomization, which may
be a limitation. Five participants consumed CHO-WP-
MPH in phase II and nine in phase III. However, when
controlling for both sequence and period effects, the
statistical analyses demonstrated no significant differ-
ences if CHO-WP-MPH was taken in phase II or in
phase III.
Our power estimation for the main trial was based on
the effects of MPH on blood sugar. Therefore, when
investigating ergogenic effects in this subanalysis, we
cannot be completely sure that we had enough partici-
pants. However, compared to several other studies [16,
Fig. 2 Mean difference in time between morning and afternoon cycling sessions. V̇O2max: maximal oxygen uptake; CHO: carbohydrate; WP: whey
protein; MPH: marine protein hydrolysate
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17, 22, 27, 30], 14 participants seems to be more than
what is commonly described. In addition, the crossover de-
sign ensures that relatively few participants are required
and the participants serve as their own control [31].
With regard to interpretation of results, the level of
aerobic capacity in this study must be taken into ac-
count. A Norwegian national cohort study [32] reported
reference values for V̇O2max to be 42.7 ± 9.3 and 36.8 ±
6.6 for men aged 40–49 and 50–59, respectively. Com-
pared to this, the participants in our study, with a mean
V̇O2max of 54.7 ± 4.1 ml∙min
− 1∙kg− 1, had a high aerobic
capacity. This corresponds well to our inclusion criteria,
requiring a large amount of weekly exercise. However,
the level of fitness in relation to possible effects of MPH
is a matter of further interest. Vegge et al. [17], with
their study investigating ingestion of MPH during en-
durance cycling, found indications that effects of MPH
could be related to aerobic capacity. Interestingly, they
found that the participants with a lower aerobic capacity
performed best after ingestion of MPH [17]. A sugges-
tion for future studies could therefore be to include less
trained participants when exploring effects of MPH.
Conclusions
In conclusion, the current study did not reveal effects of
low dose MPH supplementation in addition to WP and
CHO, compared to an isoenergetic and isonitrogenous
supplement of WP and CHO on recovery after high in-
tensity performance cycling in well-trained middle-aged
men.
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